1. A Phase I Trial of the IGF‐1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced Cancer. (23rd March 2018) Authors: Vlahovic, Gordana; Meadows, Kellen L.; Hatch, Ace J.; Jia, Jingquan; Nixon, Andrew B.; Uronis, Hope E.; Morse, Michael A.; Selim, M. Angelica; Crawford, Jeffrey; Riedel, Richard F.; Zafar, S. Yousuf; Howard, Leigh A.; O'Neill, Margot; Meadows, Jennifer J.; Haley, Sherri T.; Arrowood, Christy C.; ... Journal: Oncologist Issue: Volume 23:Number 7(2018) Page Start: 782 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Acute Pancreatitis Associated With Ado-Trastuzumab Emtansine. (March 2016) Authors: Muzaffar, Mahvish; Jia, Jingquan; Liles, Darla; Naveed, Musharraf; Kumari, Anita Journal: American journal of therapeutics Issue: Volume 23:Number 2(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Blood‐based markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance). (27th July 2016) Authors: Hatch, Ace J.; Sibley, Alexander B.; Starr, Mark D.; Brady, J. Chris; Jiang, Chen; Jia, Jingquan; Bowers, Daniel L.; Pang, Herbert; Owzar, Kouros; Niedzwiecki, Donna; Innocenti, Federico; Venook, Alan P.; Hurwitz, Herbert I.; Nixon, Andrew B. Journal: Cancer medicine Issue: Volume 5:Number 9(2016:Sep.) Page Start: 2249 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cabozantinib and Panitumumab for RAS Wild-Type Metastatic Colorectal Cancer. (9th February 2021) Authors: Strickler, John H.; Rushing, Christel N.; Uronis, Hope E.; Morse, Michael A.; Niedzwiecki, Donna; Blobe, Gerard C.; Moyer, Ashley N.; Bolch, Emily; Webb, Renee; Haley, Sherri; Hatch, Ace J.; Altomare, Ivy P.; Sherrill, Gary B.; Chang, David Z.; Wells, James L.; Hsu, S. David; Jia, Jingquan; Zafar... Journal: Oncologist Issue: Volume 26:Number 6(2021) Page Start: 465 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Cabozantinib and Panitumumab for RAS Wild‐Type Metastatic Colorectal Cancer. (9th February 2021) Authors: Strickler, John H.; Rushing, Christel N.; Uronis, Hope E.; Morse, Michael A.; Niedzwiecki, Donna; Blobe, Gerard C.; Moyer, Ashley N.; Bolch, Emily; Webb, Renee; Haley, Sherri; Hatch, Ace J.; Altomare, Ivy P.; Sherrill, Gary B.; Chang, David Z.; Wells, James L.; Hsu, S. David; Jia, Jingquan; Zafar... Journal: Oncologist Issue: Volume 26:Number 6(2021) Page Start: 465 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Dasatinib (BMS-35482) Interacts Synergistically With Docetaxel, Gemcitabine, Topotecan, and Doxorubicin in Ovarian Cancer Cells With High SRC Pathway Activation and Protein Expression. Issue 2 (1st February 2014) Authors: Secord, Angeles Alvarez; Teoh, Deanna; Jia, Jingquan; Nixon, Andrew B.; Grace, Lisa; Adams, David J.; Murphy, Susan K. Journal: International journal of gynecological cancer Issue: Volume 24:Issue 2(2014) Page Start: 218 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗